Simplex Trading
RLMD icon

Simplex Trading’s Relmada Therapeutics RLMD Stock Holding History

Simplex Trading’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,611
Closed -$88.1K – 9979
2025
Q4 		$89.9K Sell
18,611
-34,471
-65% -$115K ﹤0.01% 5100
2025
Q3 		$106K Buy
53,082
+50,655
+2,087% +$48.6K ﹤0.01% 5668
2025
Q2 		$1K Sell
2,427
-2,055
-46% -$1.05K ﹤0.01% 8410
2025
Q1 		$1K Buy
+4,482
New +$1.49K ﹤0.01% 8295
2024
Q4 		– Sell
-12,506
Closed -$30.5K – 9455
2024
Q3 		$40K Sell
12,506
-28,764
-70% -$93.2K ﹤0.01% 6092
2024
Q2 		$123K Sell
41,270
-5,443
-12% -$19.7K ﹤0.01% 5155
2024
Q1 		$217K Sell
46,713
-9,272
-17% -$44.7K ﹤0.01% 4761
2023
Q4 		$231K Buy
55,985
+17,664
+46% +$52.3K ﹤0.01% 4522
2023
Q3 		$114K Sell
38,321
-6,042
-14% -$17.9K ﹤0.01% 4959
2023
Q2 		$109K Buy
44,363
+39,859
+885% +$110K ﹤0.01% 4978
2023
Q1 		$10K Buy
+4,504
New +$15.5K ﹤0.01% 7566
2022
Q1 		– Sell
-9,143
Closed -$189K – 11241
2021
Q4 		$205K Buy
9,143
+5,057
+124% +$112K ﹤0.01% 5157
2021
Q3 		$137K Buy
4,086
+200
+5% +$5.35K ﹤0.01% 6170
2021
Q2 		$124K Sell
3,886
-4,357
-53% -$151K ﹤0.01% 6421
2021
Q1 		$290K Buy
+8,243
New +$288K ﹤0.01% 4186
2020
Q3 		– Sell
-878
Closed -$33.9K – 8383
2020
Q2 		$39K Buy
878
+353
+67% +$14.9K ﹤0.01% 5703
2020
Q1 		$17K Sell
525
-1,615
-75% -$65.1K ﹤0.01% 6095
2019
Q4 		$83K Buy
+2,140
New +$65K ﹤0.01% 4702

Other funds holding RLMD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
SSC
Spruce Street Capital New York $416M AUM
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Simplex Trading's RLMD Position: Q1 2026 in Review

Simplex Trading sold out of Relmada Therapeutics (RLMD) in Q1 2026, closing a stake of 18,611 shares — an estimated $88.1K sold.

Simplex Trading first reported a position in RLMD in Q4 2019 and held it in 18 quarters. The position peaked at $290K in Q1 2021. 103 funds tracked by Wall St. Rank hold RLMD as of Q1 2026.

  • Simplex Trading reported no remaining Relmada Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 18,611 Relmada Therapeutics shares in Q1 2026, an estimated $88.1K.
  • Simplex Trading first reported a position in Relmada Therapeutics in Q4 2019 and held it in 18 quarters.
  • Simplex Trading's Relmada Therapeutics position peaked at $290K in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.